Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 34.2 -0.52 (-1.5%) Market Cap: 1.95 Bil Enterprise Value: 1.75 Bil PE Ratio: 16.21 PB Ratio: 3.27 GF Score: 65/100

Q4 2023 Harmony Biosciences Holdings Inc Earnings Call Transcript

Feb 22, 2024 / 01:30PM GMT
Release Date Price: $31.45 (-4.70%)
Operator

Good morning. My name is Brittany and I will be your conference operator today. At this time, I would like to welcome everyone to the Harmony Biosciences Fourth Quarter and Full Year 2020 2023 financial results conference call participant lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. If you would like to ask a question at that time, please press star one on your telephone keypad. Please be advised that today's conference may be recorded last Friday. If you should require operator assistance, please press star zero. I would now like to turn the call over to Luis Sanay, Head of Investor Relations. Please go ahead.

Luis Sanay
Harmony Biosciences Holdings Inc. - Head, IR

Thank you, operator. Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences' Fourth Quarter and Full Year 2023 financial results and provide a business update.

Before we start, I encourage everyone to go to the Investors section of our website to find the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot